Table 4.
Multivariate logistic regression analysis to explore the predictive factors of non-seizure-free at different stages of follow-up.
| In the first year | In the third year | In the fifth year | |||||||
|---|---|---|---|---|---|---|---|---|---|
| B | OR (95% CI) | P -value | B | OR (95% CI) | P -value | B | OR (95% CI) | P -value | |
| Baseline seizures frequency | 0.005 | 1.005 (1.002–1.009) | 0.005 | 0.007 | 1.007 (1.004–1.010) | <0.001 | 0.005 | 1.005 (1.002–1.008) | 0.001 |
| Unconsciousness at seizure | 0.482 | 1.620 (1.318–1.990) | <0.001 | 0.499 | 1.648 (1.252–2.169) | <0.001 | |||
| Daily dosage in 1st year | 0.018 | 1.018 (1.014–1.022) | <0.001 | 0.006 | 1.006 (1.002–1.010) | 0.001 | |||
| Onset age | −0.010 | 0.990 (0.982–0.998) | 0.013 | ||||||
| Drowsiness | 0.547 | 1.727 (1.374–2.173) | <0.001 | ||||||
| Dizziness | 0.334 | 1.397 (1.072–1.820) | 0.013 | ||||||
| Ataxia | −0.398 | 0.672 (0.460–0.982) | 0.040 | ||||||